JMP Securities analyst Constantine Davides reiterated a Buy rating on Option Care Health (OPCH – Research Report) today and set a price target ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Citizens JMP raised the firm’s price target on Evolent Health (EVH) to $13 from $12 and keeps an Outperform rating on the shares. Evolent’s Q4 ...

Revenue of $646.5 million for the three months ended December 31, 2024 and $2,554.7 million for the year ended December 31, 2024, representing 16.3% and 30.1% growth over 2023, respectively.Net loss ...

Full Year 2024 Results Key Financial Results Revenue: US$2.55b (up 30% from FY 2023).

Welcome to the Evolent earnings conference call for the fourth quarter and year ended December 31, 2024. All participants ...

Evolent Health, Inc. ( NYSE: EVH) Q4 2024 Earnings Conference Call February 20, 2025 5:00 PM ET Seth Frank - Vice President, Investor Relations Seth Blackley - Chief Executive Officer John Johnson - ...

Discover key insights from Evolent Health's Q4 2024 earnings call, focusing on 30% revenue growth, contract renegotiations, projections for 2025, ...

Healthcare solutions company Evolent Health (NYSE:EVH) in Q4 CY2024, but sales rose 16.3% year on year to $646.5 million.

For the current quarter ending in March, Evolent Health said it expects revenue in the range of $440 million to $470 million. The company expects full-year revenue in the range of $2.06 billion to ...